A post-authorisation safety study (PASS) to evaluate the long-term cardiovascular and psychiatric safety profile of methylphenidate (MPH) in adult patients with attention deficit/hyperactivity disorder (ADHD) in European Countries (PASS on methylphenidate in adults)

ENCePP Code of conduct

No

Data sources

• Data source(s):
  Danish registries (access/analysis)

  National Prescribed Drugs Register / Läkemedelsregistret
• Data source(s), other:
  NorPD
• Data sources (types):
  Administrative data (e.g. claims)

  Disease registry

  Electronic healthcare records (EHR)

  Other
• Data sources (types), other:
  Exposure registry

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No